NCT01431079

Brief Summary

The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health Belief Model to enhance HPV vaccine acceptability, and (3) test the efficacy of the above intervention based on the Health Belief Model by comparing it to a knowledge-based intervention. Approximately five focus groups with ten participants in each group with college students in the ages 18-25 years will be conducted at a large Midwestern University for the qualitative piece. Data will be analyzed for categories and triangulated with previous study to develop a theory based intervention. For the quantitative piece a randomized controlled design with 45 participants in each arm (theory based intervention and knowledge based intervention) will be implemented.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

September 3, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 9, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
4 months until next milestone

Results Posted

Study results publicly available

December 10, 2012

Completed
Last Updated

February 4, 2013

Status Verified

January 1, 2013

Enrollment Period

10 months

First QC Date

September 3, 2011

Results QC Date

September 30, 2012

Last Update Submit

January 30, 2013

Conditions

Keywords

HPVCollege menHPV vaccineHealth belief modelHPV vaccine acceptance

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions the Number of Participants Who Have Taken the HPV Vaccine

    Before, after and one to three month following the health belief model based educational intervention and knowledge-based educational intervention the participants will be asked if they have taken the first dose of HPV vaccine and changes noted.

    Post intervention and up to 3 months after the interventions

  • Change From Baseline to Post Intervention to Follow-up up to 3 Months After the Interventions the Number of Participants Who Intend to Take HPV Vaccine Using HPV Intent Scale (Possible Range 0-4 Likert Units)

    Before the interventions, post test after the interventions and follow-up 1 to 3 months after the interventions (health belief model based and knowledge based) participants will be asked about their intent to take the HPV vaccine on a scale of 0-4 Likert units and changes noted. Posttest was conducted immediately after the intervention. Minimum score = 0 indicating no intent to take vaccine; Maximum score = 4 indicating strong intent to take vaccine. Scale was a single item scale.

    Post intervention and up to 3 months after the intervention

Secondary Outcomes (6)

  • Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions in Score of Perceived Susceptibility for HPV

    Post interventions and up to 3 months after the interventions

  • Change From Baseline to Post Test to Upto 3 Month Follow-up After the Interventions in Score for Perceived Severity for HPV

    Post interventions and up to 3 months after the intervention

  • Change From Baseline to Post Test After the Interventions to up to 3 Month Follow-up in Score of Perceived Benefits of HPV Vaccine

    post intervention and up to 3 months after the interventions

  • Change From Baseline to Post Test After the Interventions to Follow-up (up to 3 Months) in the Score of Perceived Barriers to Receiving HPV Vaccine

    post interventions and up to 3 months after the intervention

  • Change From Baseline to After the Interventions to Follow-up up to 3 Months After the Interventions in Score of Cues to Action to Receiving HPV Vaccine

    Post interventions and up to three months after the intervention

  • +1 more secondary outcomes

Study Arms (2)

Health belief model based education

EXPERIMENTAL

This experimental arm will provide an educational intervention designed to modify constructs of health belief model regarding HPV vaccine acceptability.

Behavioral: HPV vaccine acceptability

Knowledge-based education

ACTIVE COMPARATOR

This comparison arm will provide education based on knowledge regarding HPV vaccine acceptability.

Behavioral: HPV vaccine acceptability

Interventions

One arm will receive health belief model based educational intervention and other arm will receive knowledge-based educational intervention.

Health belief model based educationKnowledge-based education

Eligibility Criteria

Age18 Years - 25 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males
  • English speaking
  • years
  • Undergraduate or graduate student at the University of Cincinnati

You may not qualify if:

  • Females
  • Under 18 years, or above 25 years
  • Non- English speaking individuals
  • Non-university attending students
  • If already received HPV vaccination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manoj Sharma

Cincinnati, Ohio, 45221-0068, United States

Location

Related Links

Limitations and Caveats

Overall limitation of the trial were due to attrition at the one month follow up. This was due to the end of school year.This meant that students were busy preparing for finals, starting co-ops/internships, moving back home, or lack of interest.

Results Point of Contact

Title
Dr. Manoj Sharma, PI
Organization
University of Cincinnati

Study Officials

  • Manoj Sharma, Ph.D.

    University of Cincinnati

    PRINCIPAL INVESTIGATOR
  • Rebecca Lee, Ph.D.

    University of Cincinnati

    STUDY DIRECTOR
  • Purvi Mehta, MS

    University of Cincinnati

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 3, 2011

First Posted

September 9, 2011

Study Start

September 1, 2011

Primary Completion

July 1, 2012

Study Completion

August 1, 2012

Last Updated

February 4, 2013

Results First Posted

December 10, 2012

Record last verified: 2013-01

Locations